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Ερευνητικό άρθρο
ABSTRACT: This study aimed to determine lipid peroxide (LPO), antioxidant capacity (AOC), and acute-phase pro-
tein changes before and after different nebulization treatments in premature calves with respiratory distress syndrome 
(RDS).
Thirty-six premature calves were divided into equal number of 6 groups. Group 1 was labelled as negative control 
and received standard treatment. Group 2 was labelled as positive control; Groups 3, 4, 5, and 6 were labelled as trial 
groups. These groups received nebulizer treatment. Nebulizer drug combinations were as follows: Group 2 (flutica-
sone), Group 3 (formoterol + fluticasone), Group 4 (ipratropium bromide + fluticasone), Group 5 (fluticasone + furo-
semide) and Group 6 (formoterol + ipratropium bromide + furosemide + fluticasone). Venous blood was taken from 
all calves before (0 hour) and after treatment (24th, 48th, 72nd hour). It was concluded that total LPO levels gradually 
decreased while AOC levels increased during treatment but there was no difference in the serum amyloid A (SAA) and 
fibrinogen levels within groups.
In conclusion, supportive and nebulizer treatments to improve function of lungs were demonstrated to alleviate oxida-
tive stress. However, in order to reveal the effects of local nebulizer applications on oxidative stress, further studies are 
required to investigate oxidation parameters in the bronchoalveolar fluid.
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INTRODUCTION
As a widespread complication in the world and Turkey, premature calf birth is among the lead-
ing causes of mortality (Guzelbektes et al., 2012; 
Aydogdu et al., 2016; Yildiz and Ok, 2017; Yildiz et 
al., 2019; Ok et al., 2020). The majority of perinatal 
calf deaths are related to premature birth which causes 
failing to complete organ development (Meyer et al., 
2001; Johanson and Berger, 2003). Premature calves 
are born without completing the ordinary develop-
mental process, thus they may have substantial prob-
lems in circulation, nervous system, metabolism, and 
especially respiration (Yildiz and Ok, 2017; Yildiz et 
al., 2019; Ok et al., 2020). The most critical problem 
in these cases is respiratory distress syndrome, which 
is caused by the insufficient development of the lungs 
in the absence of surfactant. In premature calves with 
RDS, the lungs collapse with the development of hy-
poxia, interstitial inflammation, pulmonary hyperten-
sion due to excessive strain, and interstitial edema as 
a result of impaired air exchange due to decreased 
pulmonary compliance and surfactant deficiency. 
Death occurs in a short period if the cases are left un-
treated (Avery and Merrit, 1991). In most premature 
calves with RDS (Yildiz and Ok, 2017), respiratory 
acidosis (Ok et al., 2020), hypercapnia (Sustronck et 
al., 1996; Konduri and Kim, 2009), and hypoxemia 
(Yildiz and Ok, 2017, Yildiz et al., 2019) develop. Re-
spiratory difficulties also lead to significant hypoxia 
in tissues. This increases the production of oxidative 
stress factors and causes a decrease in antioxidant ca-
pacity (Mutinati et al., 2014). 
Hypoxia associated with lung diseases increas-
es oxidative stress products in tissues and massive 
amounts of free radicals are also formed in the or-
ganism. Lipids are the most sensitive biomolecules 
to the free radical effects. When the radicals develop 
at rates exceeding antioxidant capacity, the unsaturat-
ed bonds of cholesterol and fatty acids in the cellular 
membranes react easily with free radicals to produce 
peroxidation products (Gutterridge, 1995; Mutinati et 
al., 2014). Therefore, lipid peroxidation is the basis of 
cellular damage and can be used as an indicator of ox-
idative stress in tissues and cells (Lichtenstern et al., 
2011, Maden et al., 2012). Total LPO measurement 
determines all peroxide products in the organism. 
Antioxidant capacity (AOC) or total antioxidant pro-
tection AOP measurement carries out a crucial role 
in biological events. The presence of antioxidants is 
effective in preventing the harmful effects of free rad-
icals. Antioxidants include superoxide dismutase, cat-
alase, glutathione peroxidase enzymes and albumin, 
ferritin, ceruloplasmin, ascorbic acid, α-tocopherol, 
ß-carotene, and uric acid (Gutteridge, 1995, Halli-
well, 1997; Carole et al., 2007; Ighodaro and Akin-
loye, 2018; Gulcin et al., 2018; Gulcin, 2020). Oxi-
dative stress is the cause of impaired balance between 
oxidants and antioxidants in cells in favor of oxidants. 
In case of oxidative damage in the cell, similar to the 
tissues, damage or death occurs (Grobben et al., 1997; 
Lykkesfeldt ve Svendsen, 2007). In hypoxia-causing 
diseases (lung diseases), a significant amount of ox-
idative stress occurs and antioxidant levels decrease 
(Deaton, 2006).  Respiratory distress syndrome is the 
most important cause of mortality in preterm chil-
dren.  As a result of surfactant insufficiency, vascular 
permeability due to pulmonary hypertension increas-
es causing pulmonary edema and ischemic damage 
(Avery and Merrit, 1991). While the antioxidant lev-
els decrease in hypoxia-related ischemic damage, an 
increase in free radical LPO levels occurs (Auten and 
Davis, 2009; Kim et al., 2012). In newborns and pre-
mature, free radicals are reported to bear a very high 
risk of creating oxidative damage and oxidative stress 
(Bounocore et al., 2002; Mutinati et al., 2014).
Inflammation and edema develop in the interstitial 
tissue due to forced functioning of the lungs and hy-
pertension in the pulmonary vessels as a result of the 
surfactant insufficiency. Moreover, due to the difficul-
ties in air exchange, breathing difficulties and hypoxia 
occur in tissues. Acute-phase protein profile can be 
changed as a consequence of inflammation, edema, 
and hypoxia in the lung tissue. The most important 
positive acute-phase proteins in ruminants are fibrin-
ogen, haptoglobin (Hp), serum amyloid A (SAA), 
alpha-1 acid glycoprotein, and ceruloplasmin (Mura-
ta et al., 2004;  Eckersall and Bell, 2010, Yun et al., 
2014).  The number of acute-phase proteins increases 
in inflammation, edema, hypoxia, bacterial infection, 
or trauma and may also increase in transplantation 
and other stress situations (Murata et al., 2004; Lom-
borg et al., 2008). Serum fibrinogen, serum amyloid A 
and haptoglobin levels increases significantly during 
the inflammation process (Martinez-Subiela et al., 
2004; McGrotty et al., 2005). Acute-phase proteins 
are a group of glycoproteins produced primarily in the 
liver by leukocytes and macrophages in response to 
inflammatory mediators during (AOP) tissue damage. 
Acute-phase proteins carry out many roles in free ox-
ygen radicals, immunoglobulin production, and tissue 
repairment (Martinez-Subiela et al., 2004).
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This study aimed to determine changes in LPO, 
AOC, and acute-phase proteins before and after dif-




In this study, only premature calves of spontaneous 
birth that fulfilled the premature criteria and at least 
three criteria of respiratory distress syndrome were 
included. The criteria for premature and respiratory 
distress syndrome were determined according to the 
studies of Yildiz and Ok (2017) and Ok et al. (2020). 
All the calves were admitted from those referred to 
the clinic of the Department of Internal Medicine at 
Selcuk University, Faculty of Veterinary Medicine. 
Study was approved (2014/05) by the Ethics Board 
(SUVFEK) of Selcuk University Faculty of Veteri-
nary Medicine.
Animals
The material of the study included 36 sponta-
neously born premature calves (27 Holsteins, 5 Sim-
mentals, and 4 Montafon breeds) with respiratory 
distress syndromes. The calves were evenly randomly 
divided into 6 groups: Group 1 as a negative control, 
Group 2 as a positive control, Groups 3, 4, 5, and 6 as 
experimental groups.
Clinical Examinations and Diagnosis
The first clinical evaluation was carried out to di-
agnose the premature status of the calves referred to 
the clinic. History of the calves and premature criteria 
determined in the previous related studies were tak-
en into consideration in the evaluation of premature 
status. Calves that met premature criteria were eval-
uated whether they fulfilled the criteria of respiratory 
distress syndrome. As a result of these evaluations, 
36 calves, which fulfilled the criteria of respiratory 
distress syndrome, from 43 premature calves were in-
cluded in the study. 
Collection and Storage of Blood Samples
Venous blood samples with and without anticoag-
ulants were collected for biochemical measurement 
from calves in all groups before (0 hour) and after 
treatment (24th, 48th, 72nd hour) from Vena Jugularis 
according to the study of Ok et al. (2020). Blood sam-
ples were centrifuged at 5000 rpm, plasma and serum 
samples were collected. Plasma and sera were kept 
at -80 °C until further analysis. Venous blood SatO2 
were analysed within 15 min at 0, 24, 48 and 72 h 




Premature calves with respiratory distress syn-
drome were evenly and randomly divided into 6 
groups and the treatment protocols below were ap-
plied.
1. Group negative control (G1): Standard treatment 
protocol
2. Group positive control (G2): Standard treatment 
protocol + fluticasone 
3. Group 3 (G3): Standard treatment protocol + flut-
icasone + formoterol 
4. Group 4 (G4): Standard treatment protocol + flut-
icasone + ipratropium bromide 
5. Group 5 (G5): Standard treatment protocol + flut-
icasone + furosemide 
6. Group 6 (G6):  Standard treatment protocol + flu-
ticasone + formoterol + ipratropium bromide + 
furosemid 
Standard Treatment Protocol for Premature 
Calves
Standard treatment including oxygen supplemen-
tation and supportive treatment were provided to each 
calf in all the groups. 
Oxygen Therapy
All the premature calves received oxygen therapy 
via a mask (Figure 2) at the rate of 5 - 6 L / min per 
calf. The flow rate of oxygen was decreased to 3 to 4 
L / min after 3h. Oxygen supplementation was dis-
continued when SatO2 was > 80% after 24 hours of 
intranasal oxygen administration and if SatO2 was < 
80%, oxygen supplementation was reinstituted. 
Supportive Treatment and Clinical Care
Vitamin A - D - E combination (1 ml / day / IM 
- Ademin, Ceva Animal Health Limited), calcium 
(0.2ml / kg / day / SC - Kalsimin, Vilsan Veterinary 
Pharmaceuticals), phosphorus (3 ml / day / SC, Ca-
tosal, Bayer Animal Health), erythromycin (10 mg / 
kg / day / IM - Erivet, Mira Ilac ve Yem Katki Mad. 
Gida San. Tic. Ltd. Sti.), vitamin C (3 ml / day / SC 
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- Vitce, Sanovel Pharmaceuticals) were administered 
every day for 3 days, along with a single dose of se-
lenium - vitamin E combination (1 ml / IM, Yeldif, 
Ceva Animal Health Limited) was administrated to 
the each calf. Further, a single dose of hyperimmune 
serum (15 ml / SC, Septicol, Vetal Animal Health, 
containing Escherichia Coli serotypes K99, F41 and 
F (Y) piluses.) was administered to each premature 
calf. Intravenous fluids (0.9% NaCl and 5% dextrose) 
were administered slowly as required. 
Nebulizer Treatment Protocol for Premature 
Calves
While calves in the experimental group received 
nebulizer drugs for 5 min (Figure 3), calves in the 
control group received only 2.5 mL saline solution 
(12h, during 72h) for 5 min via a nebulizer machine. 
The nebulizer drug combinations were administered 
as follows: fluticasone for Group 2 (G2), fluticasone 
+ formoterol for Group 3 (G3), fluticasone + ipratro-
pium bromide for Group 4 (G4), fluticasone + furose-
mide for Group 5 (G5) and fluticasone + formoterol + 
ipratropium bromide + furosemide for Group 6 (G6). 
Formoterol (15 µg totally / 12h, during 72h, Ventofor, 
Bilim Pharmaceuticals),  ipratropium bromide (2 µg / 
kg / 12hr, during 72h, Atrovent, Boehringer Ingelheim 
International), furosemide (1 mg / kg / 12h, during 
72h, Lasix, Sanofi Pharmaceuticals) and fluticasone 
(15 µg / kg / 12h, during 72h, Flixotide, GlaxoSmith-
Kline Pharmaceuticals) each diluted with 2.5 mL sa-
line solution, was administered for 5 min using a neb-
ulizer machine sequentially at regular intervals during 
the study period (72h). The 0h represents the time just 
before the initiation of the treatment and immediate-
ly after the collection of blood sample the nebulized 
drugs were administered over a course of 5-20 min 
depending on the drug combination used. 
Measurement of Total Lipid Peroxide
Lipid peroxidation products were determined from 
plasma by a spectrophotometric method with com-
mercial LPO-586TM (Oxis Research, TM, Bioxytech, 
CA, 92202, USA).
Principle: The analysis is based on the reaction of 
chromogen substance N-methyl-2-phenylindole at 45 
°C with MDA and 4-hydroxialkenal (LPO). One mole 
MDA or 4-hydroxialkenal reacts with 2 molecules 
of N-methyl-2-fenilindol in acetonitrile, resulting in 
a durable chromophore at 586 nm. The results were 
defined as μMol. 
Measurement of Total Antioxidant Capacity
Total AOC was determined from plasma by spec-
trophotometric method with antioxidant capacity kit 
(Antioxidant Assay Kit, Sigma Aldrich CS O790, 
Germany). 
Principle: The reaction is based on the formation 
of ferrilmyoglobin, which is formed by hydrogen per-
oxide and myoglobin and constitutes radical ABTS+ 
cation from ABTS (2.2’-azinobis 3 ethylbenzthiazo-
line-6-sulfonic acid). Radical ABTS+ cation is a sol-
uble green chromogen that can be determined at 405 
nm. In the presence of antioxidants, radical ABTS+ 
cation formation is inhibited and color density de-
creases. As standard, a vitamin E analog, trolox, was 
used.  The results were defined as mMol.
Acute-Phase Protein Measurement
Bovine serum Amyloid A (Cat. No: 201-04-0126) 
and Bovine fibrinogen (Cat. No: 201-04-0086) lev-
els were measured on Synergy HT multi-mode mi-
croplate reader (BioTek Inc. USA) with commercial 
ELISA kit (SunRed®, China) method. The measur-
able sensitivity and test range of the SAA test was 
0.15 μg/ml to 40 μg/ml and the measurable sensitivity 
and test range of the fibrinogen test was 0.2 mg/ml to 
60 mg/ml.
Statistical Analysis
All data were presented as mean and standard errors 
(SEs) values (mean ± SEM). The distribution of the 
data was determined using the Kolmogorov-Smirnov 
test. One way Anova (Posthoc Duncan) was used for 
statistical analyses of the parameters of within groups 
by using the SPSS 21.0 software (USA). Values that 
differed significantly from the control were indicated 
as P < 0.05.
RESULTS
Lipid Peroxide
Averages and within group statistical significance 
values of the LPO levels of calves in all groups are 
presented in Table 1. 
Statistically significant decreases were detected in 
all groups at 24th, 48th, and 72nd hours compared to 
0-hour sampling time in all groups (Table 1).
Antioxidant Capacity 
Averages and within group statistical significance 
values of the AOC levels of calves in all groups are 
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presented in Table 2. 
Statistically significant increases were detected in 
all groups at 24th, 48th, and 72nd hours compared to 
0-hour sampling time in all groups (Table 2).
Acute-Phase Proteins
Serum amyloid A and fibrinogen levels measured 
in calves of all groups at all time points and their 
within group statistical significance values are pre-
sented in Table 3. There was no statistical difference 
in the SAA and fibrinogen parameters of the calves 
in all groups after the treatments compared to 0-hour 
sampling time  (Table 3).
SatO2 Percentages of Venous Blood Samples
Averages and within group statistical significance 
values of the SatO2 percentages of venous blood sam-
ples of calves in all groups are presented in Table 4. 
There was no statistical difference within G1 and G6. 
However, statistically significant increases were de-
tected within G2 at 24. and 48th. hour, G3, G4 and G5 
at 72nd. hour after the treatments compared to 0-hour 
sampling time within the groups (Table 4).
Table 1. Lipid peroxide product  levels, standard errors and statistical significance between the groups of the premature calves (Mean 
± SE).
LPO (µMol / L) 0h 24h 48h 72h
G1 0.89 ± 0.15a 0.51 ± 0.12ab 0.42 ± 0.10b 0.30 ± 0.06b
G2 0.53 ± 0.06a 0.37 ± 0.08 ab 0.43 ± 0.09ab 0.21 ± 0.01b
G3 1.04 ± 0.14a 0.57 ± 0.09b 0.50 ± 0.07b 0.46 ± 0.06b
G4 0.87 ± 0.12a 0.78 ± 0.17ab 0.47 ± 0.05ab 0.43 ± 0.04b
G5 1.27 ± 0.21a 0.73 ± 0.10b 0.69 ± 0.17b 0.57 ± 0.06b
G6 1.02 ± 0.20a 0.61 ± 0.13ab 0.47 ± 0.03b 0.41 ± 0.02b
a. b. c: Means in the same row with different letters differed significantly (P ≤ 0.05). Group negative control (G1). Group positive 
control (G2). Group 3 (G3). Group 4 (G4). Group 5 (G5). Group 6 (G6).
Table 2. Averages of total antioxidant capacity levels, standard errors and statistical significance between the groups of the premature 
calves (Mean ± SE).
AOC (mMol / L) 0h 24h 48h 72h
G1 0.54 ± 0.02b 0.59 ± 0.03ab 0.65 ± 0.01a 0.64 ± 0.02a
G2 0.51 ± 0.04b 0.57 ± 0.01ab 0.62 ± 0.02a 0.61 ± 0.02a
G3 0.48 ± 0.02b 0.55 ± 0.03 ab 0.55 ± 0.03 ab 0.58 ± 0.02a
G4 0.58 ± 0.02b 0.66 ± 0.01a 0.73 ± 0.04a 0.71 ± 0.03a
G5 0.64 ± 0.03b 0.71 ± 0.03ab 0.74 ± 0.03a 0.71 ± 0.02ab
G6 0.54 ± 0.05b 0.64 ± 0.02a 0.71 ± 0.01a 0.67 ± 0.02a
a. b. c: Means in the same row with different letters differed significantly (P ≤ 0.05).
Table 3. Serum amyloid A and fibrinogen levels, standard errors and statistical significance between the groups of the premature calves 
(Mean ± Statistics kısmında SEs yazmışız).
Parametreler 0h 24h 48h 72h
SAA
(µg / ml)
G1 0.40 ± 0.03 0.50 ± 0.06 0.32 ± 0.07 0.50 ± 0.04
G2 0.43 ± 0.03 0.49 ± 0.02 0.46 ± 0.02 0.47 ± 0.02
G3 0.50 ± 0.14 0.47 ± 0.06 0.45 ± 0.06 0.50 ± 0.14
G4 0.55 ± 0.03 0.60 ± 0.08 0.54 ± 0.06 0.55 ± 0.07
G5 0.50 ± 0.10 0.62 ± 0.04 0.64 ± 0.06 0.58 ± 0.04
G6 0.42 ± 0.11 0.48 ± 0.13 0.50 ± 0.12 0.51 ± 0.12
Fibrinojen
(mg / ml)
G1 0.35 ± 0.01 0.39 ± 0.05 0.42 ± 0.04 0.42 ± 0.03
G2 0.39 ± 0.02 0.41 ± 0.01 0.40 ± 0.01 0.39 ± 0.01
G3 0.36 ± 0.20 0.37 ± 0.16 0.41 ± 0.03 0.44 ± 0.13
G4 0.33 ± 0.11 0.41 ± 0.14 0.43 ± 0.05 0.35 ± 0.16
G5 0.43 ± 0.03 0.53 ± 0.05 0.51 ± 0.05 0.48 ± 0.03
G6 0.42 ± 0.02 0.42 ± 0.07 0.47 ± 0.02 0.43 ± 0.01
* No statistical difference within the groups.
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Table 4. SatO2 percentages of venous blood samples, standard errors and statistical significance between the groups of the premature 
calves (Mean ± SE).
SatO2 % 0h 24h 48h 72h
G1 15,67 ± 3,48 28,00 ± 6,86 21,00 ± 4,49 29,17 ± 5,33
G2 22,00 ± 3,08b 41,50 ± 4,98a 40,00 ± 6,07a 35,00 ± 4,29ab
G3 25,67 ± 2,95b 37,83 ± 4,28ab 36,67 ± 5,68ab 41,17 ± 5,19a
G4 26,00 ± 4,96b 37,83 ± 3,69ab 38,60 ± 4,4ab 44,20 ± 6,95a
G5 15,33 ± 6,26b 19,50 ± 3,15ab 26,33 ± 2,22ab 32,83 ± 6,61a
G6 20,50 ± 4,46 28,67 ± 6,15 27,20 ± 4,29 31,00 ± 7,82
a. b. c: Means in the same row with different letters differed significantly (P ≤ 0.05).
DISCUSSION
In this study, changes in LPO, AOC, and acute-
phase protein levels were evaluated before and after 
treatment in premature calves with respiratory dis-
tress syndrome (Table 1, 2, 3). Following the treat-
ment of premature calves with RDS, the total LPO 
levels decreased and antioxidant levels increased 
gradually at 24th, 48th, and 72nd hours. A decrease 
in LPO levels and increase in AOC levels following 
the treatments (Tables 1 and 2) were probably due to 
improved lung function, normal gas exchange, and 
elimination of hypoxia in the organism. These results 
were in accordance with the results of Ballard et al. 
(2008). Premature infants are extremely susceptible 
to oxidative stress since they have both increased re-
active oxygen species (ROS) formation and underde-
veloped antioxidant defenses (Ahola et al., 2004). In 
this study, it was realized that premature calves were 
as highly susceptible to oxidative stress as premature 
infants (Table 1, 2). Increased need for oxygen due to 
immature lungs and infections is thought to contribute 
to increased oxygen radical formation (Moison et al., 
1996; Laborie et al., 2000; Hirano et al., 2001; Den-
nery, 2004; Kapoor et al., 2006; von Dessauer et al., 
2010). Oxidative stress levels increase in premature 
infants in the first day and following weeks after birth 
(Buonocore et al. 2002; Perone et al., 2007).
While ROS formation increases, the antioxidant 
defense is stated to be not fully mature or present 
at birth in premature infants (Frank, 1992; Buono-
core et al. 2002; Georgeson et al., 2002; Ahola et al., 
2004; Davis and Auten, 2010). It has been reported 
that antioxidant consumption increases after birth 
and therefore AOC decreases in premature infants 
(Buhimschi, 2003). It has also been shown that the 
concentration of glutathione (GSH) in premature in-
fants declines rapidly in the early days of life (Jain et 
al., 1995; Jean-Baptiste and Rudolph, 2003; Ahola et 
al., 2004].  This is considered to be most likely due to 
increased GSH consumption associated with oxida-
tive stress. Glutathione is one of the most important 
non-enzymatic intra-cell antioxidants. Glutathione in 
the epithelial layer fluid (ELF) of the lower respirato-
ry tract is thought to be the first line of defense against 
oxidative stress (Lomaestro and Malone, 1995). The 
ELF concentration of GSH is 140 times higher than 
the serum concentration with a redox ratio of > 9:1 
(Cantin et al., 1987). In this study, the decrease in to-
tal LPO levels and the increase in AOC levels during 
the treatment of calves in both standard treatment 
and nebulizer treatment group (Table 1, 2) and no 
differences in serum total LPO levels and AOC lev-
els in the different treatment groups may be due to 
the nebulizer applications locally in the lung (Yildiz 
and Ok, 2017; Ok et al., 2020). The most satisfactory 
explanation of this condition can be the presence of 
glutathione (Cantin et al., 1987), which is found to be 
140 times more in the lungs than in the serum. In the 
present study, bronchoalveolar fluid sampling was not 
possible because premature calves had severe RDS 
symptoms which could have risked different compli-
cations. Therefore, local effects of different nebulizer 
treatment applications on oxidation parameters could 
not be evaluated, which was considered to be the lim-
itation of this research.
Hypertension in the pulmonary vessels and similar 
complications caused by surfactant insufficiency lead 
to the development of inflammation and edema in the 
interstitial tissues. As a result of inflammation, edema, 
and hypoxia in the lung tissue, changes in acute-phase 
proteins, cytokines, and coagulation profiles can oc-
cur (Murata et al., 2004; Eckersall and Bell, 2010). 
Acute-phase proteins may increase tissue damages 
caused by inflammation, edema, hypoxia, bacterial in-
fection or trauma, and following transplantations and 
other stress situations (Murata et al., 2004; Lomborg 
et al., 2008). Significant changes in serum fibrinogen, 
serum amyloid A and haptoglobin levels have been 
reported in inflammations (Martinez-Subiela et al., 
2003; McGrotty et al., 2005). In this study, SAA and 
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fibrinogen parameters were not statistically different 
at 24th, 48th, and 72nd hours compared to 0 hours 
in all groups. No changes in the acute-phase protein 
levels in the present study could be due to the fact that 
the treatments did not cause a significant change in 
serum acute-phase protein levels.
In conclusion, supportive and nebulizer treatment 
protocols were demonstrated to decrease the total lip-
id peroxide levels and improve the antioxidant capac-
ity in premature calves with RDS. However, further 
researches are needed to evaluate the local effects of 
these treatments on lung tissue and also to compare 
these effects in calves born at term without any com-
plications.
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